Ali Samiian

Ali Samiian is an experienced professional in market access and reimbursement services, currently serving as the Head of Market Access and Reimbursement Services at Saluda Medical since March 2025. Prior to this role, Samiian was Vice President of Regulatory Affairs and Reimbursement at Stoparkinson Healthcare Systems Inc. from March 2023 to May 2024, where efforts focused on developing innovative therapies for Parkinson's Disease. At Cala Health, from June 2020 to December 2022, leadership in reimbursement strategies for non-invasive neuromodulation therapies was demonstrated. Samiian's earlier roles include Directorships at Abbott and Alcon Laboratories, where responsibilities encompassed market access strategy and team management across various medical sectors. Educational qualifications include a Masters of Science in Health Economics, Policy and Management from The London School of Economics and Political Science and a JD/MBA from York University - Osgoode Hall Law School.